Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Giselle Guerra
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients 18 years of age and older
Patients who had received a solid organ (kidney, liver, lung, heart, and pancreas) transplant patient from living or deceased donors.
Patients with active graft with at least one immunosuppressive medication
Completed two doses of BNT162b2 vaccination at least 28 days ago
You may not be if
Patient with non-active graft
Any significant side effect with previous COVID-19 vaccination
Within 28 days of BNT162b2 vaccine completion
Already received more than and equal to three doses of COVID-19 vaccination
Previously received COVID-19 vaccine other than BNT162b2 vaccine
Previously received monoclonal Antibody treatment that are specifically directed against the spike protein for Severe Acute Respiratory Syndrome (SARS) Coronavirus 2 (CoV)-2 such as Mab, Bamlanivimab, etesevimab, Casirivimab, imdevimab, Sotrovimab and/or any combination.
Thrombocytopenia (if less than 50,000 per microliter 30 days prior vaccination)
History of Capillary Leak Syndrome
Adults unable to consent
Individuals who are not yet adults (younger than 18 year old)
Vulnerable patients (prisoners)
Pregnant women
Clareo Health | COVID-19 3rd Dose Vaccine in Transplant Patients
